Journal: Oncogene
Article Title: Evolutionarily conserved dual lysine motif determines the non-chaperone function of secreted Hsp90alpha in tumour progression.
PMID/MRN: 27721406
Publication Date: 2016-Oct-10
Abstract:
Both intracellular and extracellular heat shock protein-90 (Hsp90) family proteins (? and ?) have been shown to support tumour progression. The tumour-supporting activity of the intracellular Hsp90 is attributed to their N-terminal ATPase-driven chaperone function. What molecular entity determines the extracellular function of secreted Hsp90 and the distinction between Hsp90? and Hsp90? was unclear. Here we demonstrate that CRISPR/Case9 knocking out Hsp90? nullifies tumour cells' ability to migrate, invade and metastasize without affecting the cell survival and growth. Knocking out Hsp90? leads to tumour cell death. Extracellular supplementation with recombinant Hsp90?, but not Hsp90?, protein recovers tumourigenicity of the Hsp90?-knockout cells. Sequential mutagenesis identifies two evolutionarily conserved lysine residues, lys-270 and lys-277, in the Hsp90? subfamily that determine the extracellular Hsp90? function. Hsp90? subfamily lacks the dual lysine motif and the extracellular function. Substitutions of gly-262 and thr-269 in Hsp90? with lysines convert Hsp90? to a Hsp90?-like protein. Newly constructed monoclonal antibody, 1G6-D7, against the dual lysine region of secreted Hsp90? inhibits both de novo tumour formation and expansion of already formed tumours in mice. This study suggests an alternative therapeutic approach to target Hsp90 in cancer, that is, the tumour-secreted Hsp90?, instead of the intracellular Hsp90? and Hsp90?.Oncogene advance online publication, 10 October 2016; doi:10.1038/onc.2016.375.